| Autor: |
Hunsawong T, Fernandez S, Buathong R, Khadthasrima N, Rungrojchareonkit K, Lohachanakul J, Suthangkornkul R, Tayong K, Huang AT, Klungthong C, Chinnawirotpisan P, Poolpanichupatam Y, Jones AR, Lombardini ED, Wacharapluesadee S, Putcharoen O |
| Jazyk: |
angličtina |
| Zdroj: |
Emerging infectious diseases [Emerg Infect Dis] 2021 Dec; Vol. 27 (12), pp. 3178-3180. Date of Electronic Publication: 2021 Sep 24. |
| DOI: |
10.3201/eid2712.211772 |
| Abstrakt: |
In vitro determination of severe acute respiratory syndrome coronavirus 2 neutralizing antibodies induced in serum samples from recipients of the CoronaVac vaccine showed a short protection period against the original virus strain and limited protection against variants of concern. These data provide support for vaccine boosters, especially variants of concern circulate. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
